Global Intravenous Immunoglobulin Market Report By Component (IgG, IgA, IgM, IgE, IgD), By Application (Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Idiopathic Thrombocytopenic Purpura, Hypogammaglobulinemia, Myasthenia Gravis, Multifocal Motor Neuropathy, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, Others), By End-User (Hospitals, Clinics, Homecare Settings) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213403
April 2021
Report Formats:
The global demand for Intravenous Immunoglobulin Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Intravenous Immunoglobulin (IVIG) refers to a therapy that helps in treating patients with antibody deficiencies. It is a blood product made by immunoglobulin’s (antibodies) from the plasma of thousands of healthy people to fight infections. Immunoglobulin’s are glycoprotein’s which are produced from the plasma cells. As IVIG is prepared from plasma, it is highly purified so the chances of developing a blood-borne infection are exceptionally low. This therapy helps in treating a large number of diseases such as kawasaki disease, lupus, guillain-barre syndrome, myositis, chronic inflammatory demyelinating polyneuropathy (CIDP) and also immune deficiencies such as immune thrombocytopenia. In addition to this it is also used for treating some neurological diseases such as multiple sclerosis or myasthenia gravis.
 
Market Dynamics
 
The global Intravenous Immunoglobulin Market is majorly driven by growing elderly population, high prevalence of immunodeficiency diseases, growing number of hemophilic patients, increase in acceptance of IVIG treatments and rising investment in intravenous immunoglobulin medication projects. Increasing number of patients with immunodeficiency disorders is the major factor boosting the demand of Intravenous Immunoglobulin therapy. As per National Institute of Allergy and Infectious diseases (NIAID) there are over 200 different forms of primary immune deficiency diseases (PIDDs) and around 500,000 people in the United States suffering from such PIDDS.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of intravenous immunoglobulin.
 
Market Segmentation
 
The entire intravenous immunoglobulin market has been sub-categorized into component, application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Component
  • IgG
  • IgA
  • IgM
  • IgE
  • IgD
 
By Application
  • Immunodeficiency Diseases
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Idiopathic Thrombocytopenic Purpura
  • Hypogammaglobulinemia
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • Inflammatory Myopathies
  • Specific Antibody Deficiency
  • Guillain-Barre Syndrome
  • Others
 
By End-User
  • Hospitals
  • Clinics
  • Homecare Settings
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for intravenous immunoglobulin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Intravenous Immunoglobulin Market Share by Region (Representative Graph)
 
Global Intravenous Immunoglobulin Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intravenous immunoglobulin market include LFB Biotechnologies, Biotest, Octapharma, Grifols, CSL Behring, China Biologics Products, Kedrion Biopharma, BDI Pharma, Shire, CSL Behring. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Intravenous Immunoglobulin Market
       2.2. Global Intravenous Immunoglobulin Market Snapshot
 
3 . INTRAVENOUS IMMUNOGLOBULIN – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Intravenous Immunoglobulin Market
       3.3. Market Restraints of Intravenous Immunoglobulin Market
       3.4. Opportunities of Intravenous Immunoglobulin Market
       3.5. Trends of Intravenous Immunoglobulin Market
       3.6. Porter’s Five Force Analysis of Intravenous Immunoglobulin Market
       3.7. Intravenous Immunoglobulin Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Component
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by End-User
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Intravenous Immunoglobulin Value Chain Analysis
       4.2. Intravenous Immunoglobulin Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Intravenous Immunoglobulin Raw Material Manufactures List
           4.2.3. Price Trend of Intravenous Immunoglobulin Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Intravenous Immunoglobulin Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Intravenous Immunoglobulin Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Intravenous Immunoglobulin Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Intravenous Immunoglobulin Market
 
6 . GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET ANALYSIS BY COMPONENT
       6.1 Overview by Component
       6.2 Historical Data 2015-2018
       6.3 Global Intravenous Immunoglobulin Market Analysis by Component
       6.4 Market Analysis of IgG by Regions
       6.6 Market Analysis of IgA by Regions
       6.5 Market Analysis of IgM by Regions
       6.7 Market Analysis of IgE by Regions
       6.8 Market Analysis of IgD by Regions
 
7 . GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical Data 2015-2018
       7.3 Global Intravenous Immunoglobulin Market Analysis by Application
       7.4 Market Analysis of Immunodeficiency Diseases by Regions
       7.5 Market Analysis of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) by Regions
       7.6 Market Analysis of Idiopathic Thrombocytopenic Purpura by Regions
       7.7 Market Analysis of Hypogammaglobulinemia by Regions
       7.8 Market Analysis of Myasthenia Gravis by Regions
       7.9 Market Analysis of Multifocal Motor Neuropathy by Regions
       7.10. Market Analysis of Inflammatory Myopathies by Regions
       7.11 Market Analysis of Specific Antibody Deficiency by Regions
       7.12 Market Analysis of Guillain-Barre Syndrome by Regions
       7.13 Market Analysis of Others by Regions
 
8 . GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET ANALYSIS BY END-USER
       8.1 Overview by End-User
       8.2 Historical Data 2015-2018
       8.3 Global Intravenous Immunoglobulin Market Analysis by End-User
       8.4 Market Analysis of Hospitals by Regions
       8.5 Market Analysis of Clinics by Regions
       8.6 Market Analysis of Homecare Settings by Regions
 
9 . GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview and Historic Data
           9.3.2. North America Intravenous Immunoglobulin Market Estimate By Market Segment
           9.3.3. North America Intravenous Immunoglobulin Market Estimate By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview and Historic Data
           9.4.2. Europe Intravenous Immunoglobulin Market Estimate by Market Segment
           9.4.3. Europe Intravenous Immunoglobulin Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview and Historic Data
           9.5.2. Asia Pacific Intravenous Immunoglobulin Market Estimate by Market Segment
           9.5.3. Asia Pacific Intravenous Immunoglobulin Market Estimate by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview and Historic Data
           9.6.2. Latin America Intravenous Immunoglobulin Market Estimate by Market Segment
           9.6.3. Latin America Intravenous Immunoglobulin Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview and Historic Data
           9.7.2. Middle East & Africa Intravenous Immunoglobulin Market Estimate by Market Segment
           9.7.3. Middle East & Africa Intravenous Immunoglobulin Market Estimate by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE INTRAVENOUS IMMUNOGLOBULIN COMPANIES
       10.1. Intravenous Immunoglobulin Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF INTRAVENOUS IMMUNOGLOBULIN INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. LFB Biotechnologies
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Biotest
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Octapharma
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Grifols
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. CSL Behring
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. China Biologics Products
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Kedrion Biopharma
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. BDI Pharma
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Shire
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. CSL Behring
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Intravenous Immunoglobulin Market Snapshot
  • Drivers of The Global Intravenous Immunoglobulin Market Impact Analysis
  • Restraints of The Global Intravenous Immunoglobulin Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Intravenous Immunoglobulin Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Intravenous Immunoglobulin Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Intravenous Immunoglobulin Market
  • Global Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Historic Data 2015-2018
  • Global Intravenous Immunoglobulin Market Analysis in IgG by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in IgA by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in IgM by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in IgE by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in IgD by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis by Application (USD MN)
  • Historic Data 2015-2018
  • Global Intravenous Immunoglobulin Market Analysis in Immunodeficiency Diseases by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in Idiopathic Thrombocytopenic Purpura by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in Hypogammaglobulinemia by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in Myasthenia Gravis by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in Multifocal Motor Neuropathy by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in Inflammatory Myopathies by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Historic Data 2015-2018
  • Global Intravenous Immunoglobulin Market Analysis in Hospitals by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in Clinics by Geography (USD MN)
  • Global Intravenous Immunoglobulin Market Analysis in Homecare Settings by Geography (USD MN)
  • Historic Data 2015-2018
  • Global Intravenous Immunoglobulin Market by Geography (USD MN)
  • Historic Data 2015-2018
  • North America Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • North America Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • North America Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • North America Intravenous Immunoglobulin Market Estimate by Country (USD MN)
  • United State Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • United State Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • United State Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Canada Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Canada Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Canada Intravenous Immunoglobulin Market Estimate by End-User (USD MN)
  • Mexico Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Mexico Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Mexico Intravenous Immunoglobulin Market Estimate by End-User (USD MN)
  • Europe Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Europe Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Europe Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Europe Intravenous Immunoglobulin Market Estimate by Country (USD MN)
  • United Kingdom Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • United Kingdom Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • United Kingdom Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • France Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • France Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • France Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Germany Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Germany Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Germany Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Italy Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Italy Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Italy Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Russia Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Russia Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Russia Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Spain Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Spain Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Spain Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Rest of Europe Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Rest of Europe Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Rest of Europe Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Asia Pacific Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Asia Pacific Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Asia Pacific Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Asia Pacific Intravenous Immunoglobulin Market Estimate by Country (USD MN)
  • China Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • China Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • China Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Japan Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Japan Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Japan Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • India Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • India Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • India Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • South Korea Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • South Korea Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • South Korea Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Australia Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Australia Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Australia Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Rest of Asia Pacific Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Rest of Asia Pacific Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Latin America Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Latin America Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Latin America Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Latin America Intravenous Immunoglobulin Market Estimate by Country (USD MN)
  • Brazil Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Brazil Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Brazil Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Argentina Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Argentina Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Argentina Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Peru Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Peru Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Peru Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Chile Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Chile Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Chile Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Rest of Latin America Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Rest of Latin America Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Rest of Latin America Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Middle East & Africa Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Middle East & Africa Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Middle East & Africa Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Middle East & Africa Intravenous Immunoglobulin Market Estimate by Country (USD MN)
  • Saudi Arabia Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Saudi Arabia Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Saudi Arabia Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • UAE Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • UAE Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • UAE Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Israel Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Israel Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Israel Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • South Africa Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • South Africa Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • South Africa Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Rest of Middle East and Africa Intravenous Immunoglobulin Market Analysis by Component (USD MN)
  • Rest of Middle East and Africa Intravenous Immunoglobulin Market Estimate by Application (USD MN)
  • Rest of Middle East and Africa Intravenous Immunoglobulin Market Analysis by End-User (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Intravenous Immunoglobulin Report
  • Market Research Process
  • Market Research Methodology
  • Global Intravenous Immunoglobulin Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Component
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Intravenous Immunoglobulin Market Analysis by Component
  • Global Intravenous Immunoglobulin Market Analysis in IgG by Region
  • Global Intravenous Immunoglobulin Market Analysis in IgA by Region
  • Global Intravenous Immunoglobulin Market Analysis in IgM by Region
  • Global Intravenous Immunoglobulin Market Analysis in IgE by Region
  • Global Intravenous Immunoglobulin Market Analysis in IgD by Region
  • Global Intravenous Immunoglobulin Market Analysis by Application
  • Global Intravenous Immunoglobulin Market Analysis in Immunodeficiency Diseases by Region
  • Global Intravenous Immunoglobulin Market Analysis in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) by Region
  • Global Intravenous Immunoglobulin Market Analysis in Idiopathic Thrombocytopenic Purpura by Region
  • Global Intravenous Immunoglobulin Market Analysis in Hypogammaglobulinemia by Region
  • Global Intravenous Immunoglobulin Market Analysis in Myasthenia Gravis by Region
  • Global Intravenous Immunoglobulin Market Analysis in Multifocal Motor Neuropathy by Region
  • Global Intravenous Immunoglobulin Market Analysis in Inflammatory Myopathies by Region
  • Global Intravenous Immunoglobulin Market Analysis by End-User
  • Global Intravenous Immunoglobulin Market Analysis in Hospitals by Region
  • Global Intravenous Immunoglobulin Market Analysis in Clinics by Region
  • Global Intravenous Immunoglobulin Market Analysis in Homecare Settings by Region
  • Global Intravenous Immunoglobulin Market by Revenue
  • North America Intravenous Immunoglobulin Market by Revenue
  • Europe Intravenous Immunoglobulin Market by Revenue
  • Asia Pacific Intravenous Immunoglobulin Market by Revenue
  • Latin America Intravenous Immunoglobulin Market by Revenue
  • Middle East & Africa Intravenous Immunoglobulin Market by Revenue
  • Recent Development in Intravenous Immunoglobulin Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials